Skip to main content
. Author manuscript; available in PMC: 2024 Jun 21.
Published in final edited form as: J Mater Chem B. 2023 Jun 21;11(24):5390–5399. doi: 10.1039/d3tb00156c

Table 3.

Nanoparticles for endosomal targeting of GPCRs involved in pain

Nanoparticle Diameter ζ Potential (mV) Drug GPCR target
DIPMA-AP77 40.4 ± 5.1 −0.2 ± 1.6 Aprepitant NK1R
DIPMA-MK320765 30.7 ± 1.3 −1.3 ± 1.6 MK3207 CLR/RAMP1
VBA-AP78 14.5 ± 1.9 −5.8 ± 1.0 Aprepitant -NH2 NK1R
Benzo-AP78 21.1 ± 2.6 −2.1 ± 0.3 Aprepitant- NH2 NK1R
DADLE-LipoMSN-DADLE74 206.5 ± 3.3 29.9 ± 3.07 DADLE DOR